HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 357 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,940,000 | -57.2% | 49,397 | -43.6% | 0.54% | -48.3% |
| Q1 2022 | $9,207,000 | +208.6% | 87,512 | +216.1% | 1.03% | +139.4% |
| Q4 2021 | $2,983,000 | -4.9% | 27,685 | -3.4% | 0.43% | -6.7% |
| Q3 2021 | $3,138,000 | +17.0% | 28,645 | 0.0% | 0.46% | +39.5% |
| Q2 2021 | $2,682,000 | -39.8% | 28,645 | -40.8% | 0.33% | -42.0% |
| Q1 2021 | $4,455,000 | +149.7% | 48,400 | +98.4% | 0.57% | +131.6% |
| Q4 2020 | $1,784,000 | -37.8% | 24,395 | -33.9% | 0.25% | -53.5% |
| Q3 2020 | $2,868,000 | -58.1% | 36,915 | -70.0% | 0.53% | -62.0% |
| Q2 2020 | $6,848,000 | -2.3% | 123,205 | -47.9% | 1.40% | -39.7% |
| Q1 2020 | $7,010,000 | -26.7% | 236,653 | -10.4% | 2.31% | -8.7% |
| Q4 2019 | $9,558,000 | +50.1% | 264,043 | +12.9% | 2.54% | +22.1% |
| Q3 2019 | $6,368,000 | +28.2% | 233,865 | +13.3% | 2.08% | +28.6% |
| Q2 2019 | $4,968,000 | – | 206,470 | – | 1.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 6,100,000 | $377,529,000 | 27.63% |
| Kopp Family Office, LLC | 542,543 | $33,578,000 | 27.33% |
| Prosight Management, LP | 303,000 | $18,753,000 | 10.05% |
| Eversept Partners, LP | 1,269,591 | $78,574,987 | 6.81% |
| Octagon Capital Advisors LP | 624,500 | $38,650,000 | 6.67% |
| Avoro Capital Advisors LLC | 5,125,000 | $317,186,000 | 5.86% |
| 1492 Capital Management LLC | 119,836 | $7,417,000 | 5.34% |
| Velan Capital Investment Management LP | 68,829 | $4,260,000 | 4.22% |
| Deep Track Capital, LP | 1,462,800 | $90,533,000 | 4.15% |
| Ally Bridge Group (NY) LLC | 74,262 | $4,596,000 | 3.03% |